Amarin Corp. (AMRN)
0.87
+0.02 (2.35%)
Upcoming Events
Latest Headlines
Amarin to Present at the 2023 Cantor Global Healthcare Conference
September 12, 2023 8:00 AM - StreetInsider
Form SC 13D/A AMARIN CORP PLC\UK Filed by: Sarissa Capital Management LP
September 5, 2023 4:16 PM - SEC Filing
Amarin's (AMRN) new CEO buys $300k in stock as promised
August 17, 2023 10:07 AM - StreetInsider
Form 4 AMARIN CORP PLC\UK For: Aug 16 Filed by: Holt Patrick
August 16, 2023 7:52 PM - SEC Filing
Form EFFECT AMARIN CORP PLC\UK
August 16, 2023 6:02 AM - SEC Filing
Amarin (AMRN) Provides Pricing & Reimbursement Updates for VAZKEPA in The Netherlands and Italy
August 9, 2023 4:06 PM - StreetInsider
Amarin Provides Pricing & Reimbursement Updates for VAZKEPA (icosapent ethyl) in The Netherlands and Italy
August 9, 2023 4:05 PM - Globe NewsWire
Amarin Provides Pricing & Reimbursement Updates for VAZKEPA (icosapent ethyl) in The Netherlands and Italy
August 9, 2023 4:05 PM - StreetInsider
BiomX Reports Second Quarter 2023 Financial Results and Provides Business Update
August 9, 2023 6:30 AM - Globe NewsWire
Amarin (AMRN) And Neopharm Enter Exclusive Commercialization Agreement for VAZKEPA in Israel
August 8, 2023 7:02 AM - StreetInsider
Amarin And Neopharm Announce Exclusive Commercialization Agreement for VAZKEPA® (Icosapent Ethyl) in Israel
August 8, 2023 7:00 AM - Globe NewsWire
Amarin Corp. (AMRN) VAZKEPA accepted by the Scottish Medicines Consortium
August 7, 2023 7:01 AM - StreetInsider
Scottish Medicines Consortium Accepts VAZKEPA® (icosapent ethyl) to Help Reduce Cardiovascular Risk for Patients in Scotland(1)
August 7, 2023 7:00 AM - Globe NewsWire
Form 4 AMARIN CORP PLC\UK For: Aug 01 Filed by: Holt Patrick
August 2, 2023 5:07 PM - SEC Filing
Form 4 AMARIN CORP PLC\UK For: Jul 31 Filed by: Berg Aaron
August 2, 2023 5:01 PM - SEC Filing
Form 4 AMARIN CORP PLC\UK For: Jul 31 Filed by: Ketchum Steven B
August 2, 2023 5:01 PM - SEC Filing
Form S-8 AMARIN CORP PLC\UK
August 2, 2023 8:40 AM - SEC Filing
Amarin Corp. (AMRN) Files $100M Mixed Shelf
August 2, 2023 8:36 AM - StreetInsider
Form S-3 AMARIN CORP PLC\UK
August 2, 2023 8:35 AM - SEC Filing
Amarin Corp. (AMRN) Tops Q2 EPS by 5c
August 2, 2023 7:12 AM - StreetInsider
Amarin Reports Second Quarter 2023 Financial Results
August 2, 2023 7:11 AM - Globe NewsWire
Form 10-Q AMARIN CORP PLC\UK For: Jun 30
August 2, 2023 7:07 AM - SEC Filing
Form 8-K AMARIN CORP PLC\UK For: Aug 02
August 2, 2023 7:01 AM - SEC Filing
Amarin and Lotus Pharmaceuticals Announce Exclusive Partnership Agreement to Commercialize Vazkepa® (Icosapent Ethyl) in Southeast Asia and South Korea
July 31, 2023 8:00 AM - StreetInsider
Form 3 AMARIN CORP PLC\UK For: Jul 18 Filed by: Holt Patrick
July 28, 2023 6:46 PM - SEC Filing
Amarin Corp. (AMRN) Latest Research Evaluating Clinical Benefits of VASCEPA/VAZKEPA to be Presented at ESC Congress
July 26, 2023 8:01 AM - StreetInsider
Latest Research Evaluating Clinical Benefits of VASCEPA®/VAZKEPA® (icosapent ethyl) to be Presented at the European Society of Cardiology (ESC) Congress
July 26, 2023 8:00 AM - StreetInsider
Amarin Corp. (AMRN) Receives Positive Recommendation from Spanish Drug Pricing Committee for National Reimbursement of VAZKEPA
July 25, 2023 4:06 PM - StreetInsider
Amarin Receives Positive Recommendation from Spanish Drug Pricing Committee for National Reimbursement of VAZKEPA® (icosapent ethyl) in Spain
July 25, 2023 4:05 PM - StreetInsider
Form 8-K AMARIN CORP PLC\UK For: Jul 21
July 25, 2023 6:02 AM - SEC Filing
Form 4 AMARIN CORP PLC\UK For: Jul 21 Filed by: Odysseas Kostas D
July 21, 2023 9:18 PM - SEC Filing
Form 4 AMARIN CORP PLC\UK For: Jul 21 Filed by: DiPaolo Mark
July 21, 2023 9:16 PM - SEC Filing
Form 4 AMARIN CORP PLC\UK For: Jul 21 Filed by: Sterling Louis III
July 21, 2023 9:14 PM - SEC Filing
Form 4 AMARIN CORP PLC\UK For: Jul 21 Filed by: Cohen Paul
July 21, 2023 9:14 PM - SEC Filing
Form 4 AMARIN CORP PLC\UK For: Jul 21 Filed by: O'Connor Oliver
July 21, 2023 9:12 PM - SEC Filing
Form 4 AMARIN CORP PLC\UK For: Jul 21 Filed by: Horn Keith
July 21, 2023 9:08 PM - SEC Filing
Form 4 AMARIN CORP PLC\UK For: Jul 21 Filed by: Bonfiglio Patrice Eadon
July 21, 2023 9:06 PM - SEC Filing
Form 4 AMARIN CORP PLC\UK For: Jul 21 Filed by: Sullivan Diane E.
July 21, 2023 9:05 PM - SEC Filing
Form 4 AMARIN CORP PLC\UK For: Jul 19 Filed by: Berg Aaron
July 21, 2023 5:04 PM - SEC Filing
Form 4 AMARIN CORP PLC\UK For: Jul 19 Filed by: Reilly Thomas Charles
July 21, 2023 5:02 PM - SEC Filing
Form 4 AMARIN CORP PLC\UK For: Jul 19 Filed by: Ketchum Steven B
July 21, 2023 5:02 PM - SEC Filing
Form 8-K AMARIN CORP PLC\UK For: Jul 18
July 20, 2023 8:32 AM - SEC Filing
Amarin Board of Directors Announces Executive Compensation Program for New President and CEO Patrick Holt
July 20, 2023 8:00 AM - StreetInsider
Amarin Corporation (AMRN) PT Lowered to $1.25 at Northland Capital Markets
July 19, 2023 9:36 AM - StreetInsider
Amarin (AMRN) PT Lowered to $1 at Goldman Sachs, "stock to remain range bound until execution improves"
July 19, 2023 7:05 AM - StreetInsider
Form 8-K AMARIN CORP PLC\UK For: Jul 18
July 18, 2023 4:26 PM - SEC Filing
Amarin (AMRN) Appoints Patrick Holt as President and CEO
July 18, 2023 4:16 PM - StreetInsider
Amarin Corp. (AMRN) Announces Organizational Restructuring
July 18, 2023 4:16 PM - StreetInsider
Amarin Appoints Patrick Holt as President and Chief Executive Officer
July 18, 2023 4:16 PM - StreetInsider
Amarin Implements Organizational Restructuring to Strengthen the Company While Driving Patient Access to VASCEPA®/VAZKEPA® Globally
July 18, 2023 4:15 PM - StreetInsider
Form 4 AMARIN CORP PLC\UK For: Jun 20 Filed by: Reilly Thomas Charles
July 5, 2023 4:47 PM - SEC Filing
Full Article List